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Objective To observe the prognostic influences of the cardiac rehabilitation (CR) program in Korean acute 
myocardial infarction (AMI) patients during the fi  rst year after an occurrence of the disease.
Method A total of 141 AMI patients who underwent percutaneous coronary intervention (PCI) were recruited 
consecutively for this study and divided into the CR group and the control group. Th   e CR group completed the 
phase 2 CR program in the hospital for a period of 6-8 weeks and maintained self-exercise in their community by 
exercise prescription for a year after AMI. We performed a prospective comparison of the patients’ demographic 
data, high sensitive C-reactive protein (hs-CRP) level after the 4-month CR program, and the rate of recurrence 
(AMI, re-hospitalization, positive coronary angiogram, needed revascularization procedure, or death) between 
the two groups.
Results Compared to the control group (0.33±0.48 mg/dl), the hs-CRP level was lower in the CR group (0.18±0.32 
mg/dl) after 4 months of exercise. Th   e recurrence rate was lower (10%, 7/69) in the CR group, compared to the 
control group (24%, 17/72, p<0.05). The number of disease-free days was larger in the CR group (354±38.34), 
compared to the control group (316±99.96, p<0.05). In a comparison of statistical methods used for testing the 
equality of two survivor distributions, the CR group showed a lower recurrence rate than the control group (p<0.05).
Conclusion Participation in the CR program designed for AMI patients who underwent PCI-induced normalization 
of the serum hs-CRP level and lowering of the recurrence rate by 14% during the fi  rst year. 
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INTRODUCTION
  Cardiovascular diseases are the third leading cause of 
death after cancer and are on the rise, according to the 
annual data of the Korean National Statistical Office in 
2008. The mortality rate of circulatory system diseases 
is 112.3 per 100,000 members of the population. Among 
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them, mortality rates of cerebrovascular, cardiovascular, 
and hypertensive diseases are 56.5, 43.4, and 9.6 per 
100,000, respectively. Among cardiac diseases, ischemic 
heart diseases show the highest rate of mortality, at 25.7.
1
  Cardiac rehabilitation (CR) in patients with acute 
myocardial infarction (AMI) ensures more efficient 
management of risk factors, as well as improved 
cardio  pulmonary function,quality of life, and psycho-
social function. It also reduces recurrence rate, revas-
cularization rate, cardiovascular disease-related mor-
tality, and the mortality rate of non-cardiovascular 
dis eases.
2,3 In addition, findings from previous studies Chul Kim, et al.
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support that long-term CR either delays the athe-
rosclerosis process or reduces the intensiveness of the 
disease.
4,5
  As atherosclerosis, which causes coronary disease, 
has inflammatory pathogical physiology related to 
endothelial injury and atheromatous plaque rupture, 
increase of the hs-CRP level, an infl  ammatory marker, is 
the strongest predictive factor for future cardiovascular 
disease.
6-8 AMI patients require systematic management 
of risk factors, including exercise, which can provide 
more integrated and efficient adjustment of high blood 
pressure, diabetes, atherosclerosis, and dyslipidemia. CR 
can ultimately result in reduced recurrence, rehospitali-
zation, revascularization, and overall mortality rate.
9,10 
  However, there has been no comparative study of 
the recurrence and mortality rate in Koreans between 
patients who participated in CR after an occurrence 
of AMI and those in the control group. Therefore, we 
attempted to apply the CR program to AMI patients 
and determine the influences of CR on recurrence, 
revascularization, and mortality rate throughout a one-
year period of monitoring of the control group without 
CR.
MATERIALS AND METHODS
Subjects
  Patients at the cardiac rehabilitation clinic after PCI 
or coronary artery bypass graft (CABG) for AMI at the 
cardiovascular center of our hospital for the first time 
from January 2006 to December 2007 were divided 
into the exercise group and the control group for the 
study. Subjects were monitored prospectively for a 
period of one year. Patients with stroke, cancer, or 
neuromusculoskeletal symptoms that might impede CR 
program completion were excluded. Patients were asked 
to choose whether they participated in the CR or not and   
divided into the exercise group and the control group 
accordingly. Both groups maintained their medication 
for high blood pressure, diabetes, and dyslipidemia and 
were monitored in our cardiac rehabilitation clinic and 
cardiovascular outpatient center for more than a year 
after an occurrence of AMI.
Methods
  Patients in the exercise group participated in an ECG 
monitoring exercise at the hospital according to the 
exercise prescription for a period of 6-8 weeks along 
with strict management of risk factors. Prior to the CR 
program, all patients in the exercise group took the 
symptom limited exercise test using a modified Bruce 
protocol. The exercise test included use of the Q4500, 
Model 412, and Medtrack ST 55 (Quinton Instrument 
Co., Boston, USA). The exercise prescription was based 
on the initial test result. Th  e  fi  rst exercise time consisted 
of a total of 50 minutes, including warm-up (10 min), 
exercise (30 min), and cool-down (10 min). Intensity of 
exercise was adjusted on a test result basis by calculation 
of heart rate reserve first, followed by the increased 
target heart rate from 40% to 85% of the value in phases. 
Rate of Perceived Exertion (RPE) was maintained at 
13-14 (somewhat challenging). After 6-8 weeks of the 
monitoring exercise program, the exercise test was 
taken again to suggest new exercise prescriptions with 
a readjusted target heart rate and RPE. Accordingly, 
subjects were asked to maintain a self-exercise program 
in the community. 
  On the contrary, patients in the control group underwent 
general training on exercise or risk factors management 
and were instructed to maintain their own exercise 
training and cardiovascular risk factors management. 
Patients in both the exercise group and the control group 
received cardiovascular medications and underwent 
testing for hs-CRP, the infl  ammatory marker, during the 
initial stages of AMI and additionally around 4 months 
after its occurrence. Subjects in the two groups were 
monitored for a period of one year after the occurrence 
of AMI and their recurrence frequencies were compared. 
Th  e  defi  nition of recurrence included when the patients 
required hospitalization due to an occurrence of AMI 
or unstable angina, Coronary Angiography (CAG) with 
apparent angina symptoms, revascularization, such as 
PCI or CABG, and cardiovascular-related death or other 
deaths due to diff  erent causes.
2,3,11
Statistical analysis
  Chi-square analysis was used for comparison of gender 
ratio, recurrence rate, revascularization, and mortality 
rate between the two groups, while the t-test was applied 
for comparison of age and left ventricle ejection fraction 
(LVEF) between them. Comparison of the recurrence rate 
in an identity test of the survival curve in the groups used Prognostic Inﬂ  uences of Cardiac Rehabilitation in Korean AMI Patients
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the Kaplan-Meier event-free survival curve. In addition, 
the SAS Enterprise Guide 4.1 (4.1.0.471) was used as a 
statistical program and level of signifi  cance was p<0.05.
RESULTS
General characteristics of the target patients 
  No signifi  cant diff  erences in general characteristics such 
as gender ratio and patient’s age were observed between 
the exercise group (69) and the control group (72) (p>0.05, 
Table 1). Th   e LVEF of the exercise group (54.53±13.66%) 
before the CR program was higher than that of the control 
group (50.11±12.74%); however, the difference was not 
statistically signifi  cant.
Comparison of hs-CRP and HbA1C levels between the 
exercise group and the control group
  The exercise group (0.18±0.32 mg/dl) showed a 
signifi  cantly lower value of hs-CRP than the control group 
(0.33±0.48 mg/dl) at around 4 months after an occurrence 
of AMI (p<0.05, Fig. 1). Th   e exercise group only showed 
normalized hs-CRP. No noticeable diff  erences in hs-CRP 
prior to exercise were observed between the exercise 
group (1.74±4.02 mg/dl) and the control group (3.19±4.67 
mg/dl) (p>0.05, Table 2). Additionally, the exercise group 
included 2 patients (3%) with unadjustable diabetes 
with an HbA1c level over 6, lower than that of the control 
group, which included 4 patients (3%) (p>0.05, Table 3).
Recurrence rate and death rate between the exercise 
group and the control group for a period of one year 
  The recurrence rate was monitored for a period of 1 
year; results showed recurrence in 7 patients (10%) in 
the exercise group, and 17 patients (24%) in the control 
group, indicating a signifi  cantly lower rate in the exercise 
group (p<0.05). Among the 7 patients, 2 received CAG 
Table 1. Characteristics of Subjects 
Exercise
group
(n=69)
Control
group
(n = 72)
p-value
Male/female 49/20 60/12 0.08
Age (year) 61.93±10.67 64.49±9.31 0.13
LVEF (%)  54.53±13.66   50.11±12.74 0.07
PTCA/CABG 64/5 66/6 0.81
BP medication 62 (90%) 68 (94%) 0.36
DM medication 17 (25%) 12 (17%) 0.24
Statin 60 (87%) 64 (89%) 0.70
LVEF: Left ventricular ejection fraction, PTCA: Percu  ta-
neous transluminal coronary angioplasty, CABG: Coro  -
nary artery bypass graft, BP: Blood pressure, DM: Dia-
betes mellitus
Fig. 1. Comparison of the hs-CRP level between the CR 
group and the control group 4 months after CR program 
completion. 
Table 2. Comparison of hs-CRP Levels between the CR 
Group and Control Group 4 Months after CR Program 
Completion
Exercise 
group 
(n=69)
Control 
group 
(n=72)
p-value
Baseline hs-CRP
 (mg/dl)
1.74±4.02 3.19±4.67 0.08
hs-CRP (mg/dl)
 4 months after
 the CR program
0.18±0.32 0.33±0.48   0.03*
hs-CRP: High sensitivity C-reactive protein, CR: Cardiac 
rehabilitation
*p<0.05
Table 3. Comparison of HbA1c Levels between the CR 
Group and Control Group 4 Months after CR Program 
Completion
Exercise 
group
(n=69)
Control 
group
(n=72)
p-value
Uncontrolled DM
 (HbA1c>6)
2 (3%) 4 (6%) 0.68
HbA1c: Hemoglobin A1c, CR: Cardiac rehabilitation, 
DM: Diabetes mellitusChul Kim, et al.
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(3%) and 4 underwent revascularization surgery (6%), 
1 patient died (1.4%) after the recurrence. The control 
group included 2 patients who underwent process 
monitoring after hospitalization (3%), 7 who underwent 
coronary angiography (10%), 7 who underwent revas-
culari  zation surgery (10%), and 1 death (>1%).
Kaplan-Meier curve of disease-free days and disease-
free rate between the exercise group and the control 
group
  Compared with the control group (316±99.96 days), 
the exercise group had a noticeably larger number of 
disease-free days (354±38.34 days) during a period of 
one year after the initial stages of AMI (p<0.05, Table 4). 
In an identity test of the survival curve in the two groups, 
the recurrence rate showed a more signifi  cant reduction 
(14%) in the exercise group than in the control group (p< 
0.05, Fig. 2). As a result, participation in the CR program 
resulted in extension of the number of disease-free days 
for AMI patients after the occurrence of disease.
 
DISCUSSION
  Endothelial injury and atheromatous plaque rupture 
are inflammatory conditions caused by smoking and 
hyperglycemia and are involved in the atherosclerotic 
process.
12-15 As the atherosclerotic process develops, 
infl  ammation caused by macrophagic transformation and 
migration, oxidation, and thrombosis occurs, and blood 
infl  ammatory protein, which takes part in infl  ammation, 
is increased accordingly. The inflammatory marker hs-
CRP is generally regarded as the most sensitive for future 
cardiovascular risk.
6 This study demonstrated a marked 
reduction of hs-CRP in the exercise group patients who 
participated in the CR program.
  Management of intensive risk factors, including exercise 
training in patients with coronary artery disease, is 
known to elicit significant recovery of atherosclerosis 
and coronary artery obstructive disease and reduction 
of recurrence rate.
16 In particular, the exercise-induced 
CR program for patients with coronary artery disease is 
known to increase the survival rate and is effi   cient for use 
in risk factors management of coronary artery diseases.
12 
Patients who participated in the CR program and who 
had had PCI or CABG after AMI have been reported 
to result in enhanced management of risk factors and 
extended disease-free days.
9,10 It is also known to reduce 
the mortality rate caused by cardiovascular and other 
diseases by approximately 20%.
2,3
  Results from this study showed that the recurrence rate 
for patients in the exercise group who participated in 
the CR program was reduced by about 14% compared to 
the control group. Th   is result is somewhat diff  erent from 
the 18-20% reduction reported elsewhere.
2,3,11 It can be 
attributed to differences of race, severity of disease, CR 
treatment period in the hospital, and compliance with 
the continuous self-exercise program in the community. 
Hammill reported that extension of the CR program up 
to 36 weeks resulted in a remarkable reduction of the 
mortality rate and rehospitalization rate in patients with 
coronary artery disease who received CABG by Medicare, 
the medical insurance system for the elderly and people 
Table 4. Cerebrovascular Events during a 1-year Period 
after the First AMI
Exercise 
group
(n=69)
Control
group
(n=72)
p-value
Disease free days 354±38.34 316±99.96   0.003*
Recurrence   7 (10%) 17 (24%)   0.033*
Need revascularization 4 (6%)   7 (10%) 0.533
Positive CAG 2 (3%)   7 (10%) 0.166
Need hospitalization 0 (0%) 2 (3%) 0.497
Death     1 (1.4%)   1 (>1%) 0.953
AMI: Acute myocardial infarction, CAG: Coronary angio-
graphy 
*p<0.05
Fig. 2. Kaplan Meier event-free survival curve during the fi  rst 
year after acute myocardial infarction.Prognostic Inﬂ  uences of Cardiac Rehabilitation in Korean AMI Patients
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with disability in the US.
11
  In this study, the exercise group showed a greater 
reduction (14%) in recurrence rate and 38 more disease-
free days than the control group during the one-year 
monitoring period after strict risk factors management 
and 6-8 weeks of monitoring in the hospital, followed by 
self-exercise in the community after the initial occurrence 
of AMI in their lives. Taylor et al.
2 reported reduction of 
the total mortality rate (20%), cardiovascular disease 
mortality rate (26%), total cholesterol level, triglyceride 
level, systolic blood pressure, and self-reported smoking 
rate in the exercise group; however, no distinctive 
differences in nonfatal re-infarction, revascularization 
rate, high density and low density lipoprotein cholesterol, 
and diastolic pressure were observed between the 
exercise group and the control group. Moreover, although 
O’Connor et al.
3 reported greater reduction of total 
mortality rate (20%), cardiovascular disease mortality 
rate (22%), and fatal re-infarction (25%) compared to the 
control group, during the 3-year monitoring period, no 
signifi  cant diff  erence was found in nonfatal re-infarction 
between the two groups.
  Th   e limitation in this study is that the exercise group and 
the control group were not chosen randomly and that a 
monitoring period of one year was too short for suffi   cient 
progress monitoring. Also, 1 death in each group during a 
period of one year was not supportive for comparison of 
the mortality rate between them. 
  Nevertheless, this study is important because it is the 
fi  rst to compare the recurrence rate and the mortality rate 
between patients in the exercise group, who participated 
in the CR program, and those in the control group, who 
did not, throughout a one-year period of monitoring of 
Korean patients. Further studies for comparison of the 
recurrence rate and the mortality rate on a continuous 
monitoring basis will be required.
CONCLUSION
  Th   e exercise group showed a greater reduction (14%) of 
the recurrence rate and 38 more disease-free days than 
the control group during the one-year monitoring period 
after strict risk factors management and 6-8 weeks of 
monitoring in the hospital, followed by self-exercise in 
the community after the initial occurrence of AMI in their 
lives. hs-CRP of the exercise group at around 4 months 
after occurrence of the disease was reduced by 50% of 
that of the control group.
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